{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:14:24Z","timestamp":1791501264351,"version":"4.3.4"},"reference-count":58,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONTEXT<\/jats:title>\n                    <jats:p>Urinary tract infections (UTIs) are common in young infants, yet there is no guidance on the optimal duration of intravenous (IV) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine if shorter IV antibiotic courses (\u22647 days) are appropriate for managing UTIs in infants aged \u226490 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>PubMed, the Cochrane Library, Medline, and Embase (February 2021) were used as data sources. Included studies reported original data for infants aged \u226490 days with UTIs, studied short IV antibiotic durations (\u22647 days), and described at least 1 treatment outcome. The Preferred Reporting Items for Systematic Reviews and Meta-analyses guideline was followed. Studies were screened by 2 investigators, and bias was assessed by using the Newcastle-Ottawa Scale and the Revised Cochrane Risk-of-Bias Tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Eighteen studies with 16\u2009615 young infants were included. The largest 2 studies on bacteremic UTI found no difference in the rates of 30-day recurrence between those treated with \u22647 vs &amp;gt;7 days of IV antibiotics. For nonbacteremic UTI, there was no significant difference in the adjusted 30-day recurrence between those receiving \u22643 vs &amp;gt;3 days of IV antibiotics in the largest 2 studies identified. Three studies of infants aged \u226530 days used oral antibiotics alone and reported good outcomes, although only 85 infants were \u226490 days old.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Shorter IV antibiotic courses of \u22647 days and \u22643 days with early switch to oral antibiotics should be considered in infants aged \u226490 days with bacteremic and nonbacteremic UTI, respectively, after excluding meningitis. Further studies of treatment with oral antibiotics alone are needed in this age group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2021-052466","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T03:12:58Z","timestamp":1643080378000},"source":"Crossref","is-referenced-by-count":21,"title":["Short Intravenous Antibiotic Courses for Urinary Infections in Young Infants: A Systematic Review"],"prefix":"10.1542","volume":"149","author":[{"given":"Samar","family":"Hikmat","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases & Microbiology Research Group, Murdoch Children\u2019s Research Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"issue":"6","key":"2022040814555882600_B1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/INF.0000000000000225","article-title":"The changing epidemiology of serious bacterial infections in young infants","volume":"33","author":"Greenhow","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2022040814555882600_B2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/INF.0b013e31815e4122","article-title":"Prevalence of urinary tract infection in childhood: a meta-analysis","volume":"27","author":"Shaikh","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2022040814555882600_B3","doi-asserted-by":"crossref","first-page":"e2020012138","DOI":"10.1542\/peds.2020-012138","article-title":"Contemporary management of urinary tract infection in children","volume":"147","author":"Mattoo","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"2022040814555882600_B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3810\/pgm.2001.01.836","article-title":"Recognizing UTIs in infants and children. Early treatment prevents permanent damage","volume":"109","author":"Bartkowski","year":"2001","journal-title":"Postgrad Med"},{"issue":"1","key":"2022040814555882600_B5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/1678-4685-jbn-3602","article-title":"Clinical and laboratory features of urinary tract infections in young infants","volume":"40","author":"Lo","year":"2018","journal-title":"J Bras Nefrol"},{"key":"2022040814555882600_B6","unstructured":"National Institute for Health and Care Excellence\n          . Urinary tract infection in under 16s: diagnosis and management. Available at: https:\/\/www.nice.org.uk\/guidance\/cg54. Published August 22, 2007. Updated October 31, 2018. Accessed October 2, 2020"},{"key":"2022040814555882600_B7","unstructured":"The Royal Children\u2019s Hospital Melbourne\n          . Clinical practice guideline on urinary tract infection. Available at: https:\/\/www.rch.org.au\/clinicalguide\/guideline_index\/Urinary_tract_ infection\/. Updated July 2019. Accessed October 2, 2020"},{"key":"2022040814555882600_B8","unstructured":"Perth Children\u2019s Hospital\n          . Emergency Department Guidelines on urinary tract infection. Available at: https:\/\/pch.health.wa.gov.au\/For-health- professionals\/Emergency-Department- Guidelines\/Urinary-tract-infection. Updated April, 2020. Accessed October 2, 2020"},{"key":"2022040814555882600_B9","unstructured":"Children\u2019s Health Queensland Hospital and Health Service\n          . Clinical practice guideline on urinary tract infection\u2013emergency management in children. Available at: https:\/\/www.childrens.health.qld.gov.au\/wp-content\/uploads\/PDF\/guidelines\/CHQ-GDL-60026-urinary- tract-infection.pdf. Accessed October 2, 2020"},{"key":"2022040814555882600_B10","unstructured":"Clark\n              K\n            , JamisonS, BellA, PrimhakS, WilliamsG, WongW. Starship clinical guidelines: urinary tract infection. Available at: https:\/\/www.starship.org.nz\/guidelines\/urinary-tract-infection\/. Published March 12, 2020. Accessed October 2, 2020"},{"issue":"3","key":"2022040814555882600_B11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months","volume":"128","author":"Roberts","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2022040814555882600_B12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1542\/peds.2009-2948","article-title":"Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections","volume":"126","author":"Brady","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"2022040814555882600_B13","first-page":"e1","article-title":"Diagnosis and management of UTI in febrile infants age 0-2 months: applicability of the AAP Guideline","volume":"15","author":"Chang","year":"2020","journal-title":"J Hosp Med"},{"issue":"1","key":"2022040814555882600_B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1542\/hpeds.2017-0082","article-title":"Physician preferences surrounding urinary tract infection management in neonates","volume":"8","author":"Joshi","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"6","key":"2022040814555882600_B15","doi-asserted-by":"crossref","first-page":"e20171021","DOI":"10.1542\/peds.2017-1021","article-title":"Trends in intravenous antibiotic duration for urinary tract infections in young infants","volume":"140","author":"Lewis-de Los Angeles","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2022040814555882600_B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/hpeds.2014-0051","article-title":"Diagnosis and management of bacteremic urinary tract infection in infants","volume":"5","author":"Roman","year":"2015","journal-title":"Hosp Pediatr"},{"issue":"2","key":"2022040814555882600_B17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/archdischild-2014-307997","article-title":"Bacteraemic urinary tract infection: management and outcomes in young infants","volume":"101","author":"Schroeder","year":"2016","journal-title":"Arch Dis Child"},{"issue":"1","key":"2022040814555882600_B18","doi-asserted-by":"crossref","first-page":"e000487","DOI":"10.1136\/bmjpo-2019-000487","article-title":"Urinary tract infections in children: an overview of diagnosis and management","volume":"3","author":"Kaufman","year":"2019","journal-title":"BMJ Paediatr Open"},{"issue":"2","key":"2022040814555882600_B19","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1473-3099(17)30345-6","article-title":"Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review","volume":"18","author":"Bryant","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2022040814555882600_B20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamapediatrics.2013.775","article-title":"Risk factors for peripherally inserted central venous catheter complications in children","volume":"167","author":"Jumani","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"71","key":"2022040814555882600_B21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2022040814555882600_B22","unstructured":"Wells\n              GA\n            , SheaB, O\u2019ConnellD, . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital website. Available at: www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed February 7, 2021"},{"key":"2022040814555882600_B23","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2022040814555882600_B24","unstructured":"Oxford Centre for Evidence-Based Medicine-levels of evidence. Available at: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for- evidence-based-medicine-levels-of- evidence-march-2009. Published March 2009. Accessed February 7, 2021"},{"issue":"2","key":"2022040814555882600_B25","first-page":"98","article-title":"Urinary tract infection in neonates: how aggressive a workup and therapy?","volume":"20","author":"Ashouri","year":"2003","journal-title":"Infect Med"},{"issue":"6","key":"2022040814555882600_B26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/INF.0000000000000316","article-title":"Factors associated with bacteremia in young infants with urinary tract infection","volume":"33","author":"Averbuch","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2022040814555882600_B27","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1542\/peds.2011-0814","article-title":"Randomized trial of oral versus sequential IV\/oral antibiotic for acute pyelonephritis in children","volume":"129","author":"Bocquet","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"2022040814555882600_B28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.pec.0000113876.10140.9b","article-title":"Clinical course of urinary tract infections in infants younger than 60 days of age","volume":"20","author":"Dayan","year":"2004","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"2022040814555882600_B29","doi-asserted-by":"crossref","first-page":"e20183844","DOI":"10.1542\/peds.2018-3844","article-title":"Parenteral antibiotic therapy duration in young infants with bacteremic urinary tract infections","volume":"144","author":"Desai","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"2022040814555882600_B30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/peds.2008-2583","article-title":"Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics","volume":"124","author":"Dor\u00e9-Bergeron","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2022040814555882600_B31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jpids\/piz037","article-title":"Oral narrow-spectrum antibiotics for the treatment of urinary tract infection in infants younger than 60 days","volume":"9","author":"Fernandez","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1 Pt 1","key":"2022040814555882600_B32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.104.1.79","article-title":"Oral versus initial intravenous therapy for urinary tract infections in young febrile children","volume":"104","author":"Hoberman","year":"1999","journal-title":"Pediatrics"},{"issue":"2","key":"2022040814555882600_B33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PEC.0b013e3180302c47","article-title":"Efficacy of short-term intravenous antibiotic in neonates with urinary tract infection","volume":"23","author":"Mag\u00edn","year":"2007","journal-title":"Pediatr Emerg Care"},{"issue":"9","key":"2022040814555882600_B34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1542\/hpeds.2019-0325","article-title":"Relationship between clinical factors and duration of IV antibiotic treatment in neonatal UTI","volume":"10","author":"Marsh","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"4","key":"2022040814555882600_B35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00467-011-2087-3","article-title":"Managing children under 36 months of age with febrile urinary tract infection: a new approach","volume":"27","author":"Pennesi","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2022040814555882600_B36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1542\/peds.2010-0479","article-title":"Febrile infants with urinary tract infections at very low risk for adverse events and bacteremia","volume":"126","author":"Schnadower","year":"2010","journal-title":"Pediatrics"},{"issue":"7","key":"2022040814555882600_B37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archpediatrics.2011.104","article-title":"Sterile cerebrospinal fluid pleocytosis in young febrile infants with urinary tract infections","volume":"165","author":"Schnadower","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"2022040814555882600_B38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1542\/hpeds.2020-0178","article-title":"Urinary tract infection in young infants: practice patterns in evaluation and treatment","volume":"10","author":"Swartz","year":"2020","journal-title":"Hosp Pediatr"},{"key":"2022040814555882600_B39","unstructured":"National Institute for Health and Care Excellence\n          . Pyelonephritis (acute): antimicrobial prescribing. Available at: https:\/\/www.nice.org.uk\/guidance\/ng111. Published October 31, 2018. Accessed October 2, 2020"},{"key":"2022040814555882600_B40","unstructured":"National Institute for Health and Care Excellence\n          . Urinary tract infection (lower): antimicrobial prescribing. Available at: https:\/\/www.nice.org.uk\/guidance\/ng109. Published October 31, 2018. Accessed October 2, 2020"},{"issue":"11","key":"2022040814555882600_B41","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/jac\/dkz252","article-title":"Oral antibiotics for neonatal infections: a systematic review and meta-analysis","volume":"74","author":"Keij","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022040814555882600_B42","unstructured":"Electronic Medicines Compendium (EMC)\n          . Co-Trimoxazole Tablets 80\/400mg. Updated March 10, 2021. Accessed February 21, 2021. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/5752\/smpc#gref"},{"key":"2022040814555882600_B43","first-page":"16","article-title":"The pharmacology of cephalexin","volume":"59","author":"Griffith","year":"1983","journal-title":"Postgrad Med J"},{"issue":"4","key":"2022040814555882600_B44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/iai.3.4.540-543.1971","article-title":"Cephalexin: absorption and excretion as related to renal function and hemodialysis","volume":"3","author":"Reisberg","year":"1971","journal-title":"Infect Immun"},{"issue":"3","key":"2022040814555882600_B45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJMoa021698","article-title":"Imaging studies after a first febrile urinary tract infection in young children","volume":"348","author":"Hoberman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"2022040814555882600_B46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.juro.2008.09.039","article-title":"Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature","volume":"181","author":"Faust","year":"2009","journal-title":"J Urol"},{"issue":"10","key":"2022040814555882600_B47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00006454-200110000-00003","article-title":"Sterile cerebrospinal fluid pleocytosis in young infants with urinary tract infection","volume":"20","author":"Syrogiannopoulos","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"2022040814555882600_B48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/INF.0b013e31829063cd","article-title":"Cerebrospinal fluid pleocytosis in febrile infants 1-90 days with urinary tract infection","volume":"32","author":"Doby","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"2022040814555882600_B49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1440-1754.2009.01502.x","article-title":"Incidence of sterile cerebrospinal fluid pleocytosis in infants with urinary tract infection","volume":"45","author":"Yam","year":"2009","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"2022040814555882600_B50","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/01.inf.0000100576.99266.07","article-title":"Aseptic meningitis in infants younger than six months of age hospitalized with urinary tract infections","volume":"22","author":"Adler-Shohet","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2022040814555882600_B51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.298.2.179","article-title":"Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials","volume":"298","author":"Conway","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"2022040814555882600_B52","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1542\/peds.2015-0409","article-title":"Risk factors for recurrent urinary tract infection and renal scarring","volume":"136","author":"Keren","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"2022040814555882600_B53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s004670000493","article-title":"Recurrence and follow-up after urinary tract infection under the age of 1 year","volume":"16","author":"Nuutinen","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"2022040814555882600_B54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapediatrics.2014.637","article-title":"Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data","volume":"168","author":"Shaikh","year":"2014","journal-title":"JAMA Pediatr"},{"key":"2022040814555882600_B55","first-page":"0306","article-title":"Urinary tract infection in children","volume":"2010","author":"Larcombe","year":"2010","journal-title":"BMJ Clin Evid"},{"issue":"4","key":"2022040814555882600_B56","first-page":"CD003237","article-title":"Modes of administration of antibiotics for symptomatic severe urinary tract infections","volume":"2007","author":"Pohl","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2022040814555882600_B57","first-page":"CD003772","article-title":"Antibiotics for acute pyelonephritis in children","author":"Strohmeier","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"2022040814555882600_B58","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1185\/03007990802550679","article-title":"Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials","volume":"24","author":"Vouloumanou","year":"2008","journal-title":"Curr Med Res Opin"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-052466\/1278017\/peds_2021052466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-052466\/1278017\/peds_2021052466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T10:57:16Z","timestamp":1649415436000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/2\/e2021052466\/184548\/Short-Intravenous-Antibiotic-Courses-for-Urinary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,25]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-052466","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741549796.793592112","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"article-number":"e2021052466"}}